Skip to content

Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.

Preliminary Descriptive Exploratory Pilot Study Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04021459
Acronym
E-CTC
Enrollment
15
Registered
2019-07-16
Start date
2019-09-16
Completion date
2021-09-16
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer

Keywords

endometrial cancer, circulating tumor cells, laparoscopy

Brief summary

The purpose of this study is to investigate the spread of Circulating Tumor Cells (CTC) during surgery in endometrial cancer. Although this cancer is often discovered at early stage, the risk of recurrence is estimated at 6 to 21%, according to grade. Early stage tumor is accessible for curative surgical treatment by laparoscopy but this kind of surgery may induce CTCs spread, and could be an explanation of this recurrence. Through this study, concordance between two blood punction sites, peripheral vein and ovarian vein, will be evaluated to detect these cells during surgery.

Detailed description

The goal of this single-center clinical trial is to determine the best blood punction site to observe the spreading of CTC during surgery in endometrial cancer. CTCs are very rare events on blood and their detection require extremely sensitive technologies. This pilot study will investigate CTC spread during surgery on 10 patients with endometrial cancer. The main objective is to compare venipuncture site for detection of CTCs in endometrial cancer during surgery. Blood samples are collected on a simple sampling (arm) compared to sampling as close as possible to the tumor (ovarian vein).

Interventions

PROCEDUREblood samples

3 samples: One before surgery on the arm vein (peripheral) Two during the surgery, on two different venipuncture site : * One on the arm vein (peripheral) * One on ovarian vein (close to the tumor) All samples will be tested by the CellSearch method.

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

women with endometrial cancer

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with endometrial cancer * Being affiliated or benefiting from a French social security system

Exclusion criteria

* Patients with an other cancer

Design outcomes

Primary

MeasureTime frameDescription
Qualitative assessmentDuring surgery (at the ligature of the ovarian ligament)Presence or not of at least one CTC during endometrial cancer surgery detected on two venipuncture site (peripheral and ovarian vein).

Secondary

MeasureTime frameDescription
Quantitative assessmentBefore surgery and during surgeryNumber of CTC detected from each sampling

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026